CD8A and neoplasm: These observations could indicate that COX2/PGE2 may serve as a barrier preventing CD8+ T-cell infiltration into the tumor core (Supplementary Fig. S3B 4T1 tumors), thus facilitating the development of an immune desert, which is consistent with increased CD8+ T-cell penetration into the core associated with COX inhibition by NSAID treatment (11).